Active Pharmaceutical Ingredients Market by API Type (Biological, Chemical), Drug (Branded, Generic, OCT), Manufacturing (In-House, Outsourcing or Contact-Based), Therapeutic Area (Diabetes, Cardiovascular, CNS, NSAIDS, Oncology, Musculoskeletal Drugs) and Forecast 2017-2021

Active Pharmaceutical Ingredients Market by API Type (Biological, Chemical), Drug (Branded, Generic, OCT), Manufacturing (In-House, Outsourcing or Contact-Based), Therapeutic Area (Diabetes, Cardiovascular, CNS, NSAIDS, Oncology, Musculoskeletal Drugs) and Forecast 2017-2021

Active Pharmaceutical Ingredients (API) are portions of any active drug, depending on the drug’s administered dosage, the reactions and therapeutic results. Certain drugs are comprised of more than one kind of active ingredient. API drug manufacturing, storage and packaging is subject to Current Good Manufacturing Process (cGMP) regulations enforced by the U.S. FDA, EMEA and other international regulatory agencies.

The global active pharmaceutical ingredients market report estimates the market size (Revenue USD million – 2014 to 2021) for key market segments based on the API (biological, chemical), Drug (branded, generic, OTC), manufacturing (in-house, outsourcing or contact-based), therapeutic area (diabetes, cardiovascular, CNS, NSAIDs, oncology, musculoskeletal drugs, etc.), and forecasts growth trends (CAGR% – 2017 to 2021).

By manufacturing type, in-house API manufacturing segment contributed to the highest market share of the global active pharmaceutical ingredients market, while by therapeutic area, cardiovascular drug APIs segment accounted for the largest share of the global market.

The global active pharmaceutical ingredients market segmentation is based on geography (regional and country based). The global active pharmaceutical ingredients market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global active pharmaceutical ingredients market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

The major players profiled in the report include Boehringer Ingelheim Group, Cambrex Corporation, Dr. Reddy’s Laboratories, Ltd., BASF SE, Hospira, Inc., Lonza Group, Mylan, Inc., Novartis AG, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Actavis plc, and Wuxi Apptec.

Category:
  1. Introduction
  2. Executive Summary
    • Market Size Estimation (Revenue USD Million, 2014-2021)
    • Forecast Estimation (Revenue USD Million and CAGR%, 2017-2021)
  3. Research Methodology
  4. Market Landscape
    • Market Dynamics
      • Drivers
      • Barriers
      • Opportunities
    • Market Share Analysis
      • Companies
      • Drugs
    • Market Trends Analysis
      • Key success factors
      • Market Growth Rate
    • Market Attractiveness Analysis
    • Market Profitability Analysis
      • Buyer power
      • Supplier power
      • Barriers to entry
      • Threat of substitute products
      • Rivalry among firms in the industry
    • Distribution Channels
  5. Market Segmentation [refer Market Segments and Companies Tab]
    • Drug Class or Drug (Brand) Type
    • Drug or Disorder Test
    • Indication Type
    • Drug Treatment
    • Mechanism of Action
    • Therapeutic Area or Nature of Application
    • End User Groups
  6. Geography (Region, Country)
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World (Middle East & Africa)
  7. Regulatory Overview 
    • IND, NDA filed, FDA, EMEA Approvals
  8. Pipeline Analysis(Phase 1, 2 and 3 Drugs)
    • Phase 3 Drugs Forecast Estimation (Approval to 2025)
    • Phase 1 and 2 Drugs – Qualitative Analysis
  9. Company Profiles [refer Market Segments and Companies Tab]
    • Company Overview
    • Financial Snapshot (FY 2014-2016)
    • Product Portfolio
    • Business Strategies
    • Recent Developments
  10. Recommendations
  11. References

Active Pharmaceutical Ingredients (API) Market

1. Active Pharmaceutical Ingredient
1.1. Biological
1.2. Chemical

2. Drug
2.1. Branded (Innovative) Prescription Drugs
2.2. Generic Prescription Drugs
2.3. Over-the-counter (OTC) Drugs

3. Manufacturing
3.1. Contract or Outsourcing Manufacturing
3.2. Captive (In-House) Manufacturing

4. Therapeutic Area
4.1. Anti-diabetic Drugs
4.2. Cardiovascular Drugs
4.3. Central Nervous System Drugs
4.4. Musculoskeletal Drugs
4.5. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
4.6. Oncology Drugs
4.7. Other Drugs (Antibacterial, Antiviral, Antifungal)

5. Company Profiles
5.1. Actavis plc.
5.2. BASF SE
5.3. Boehringer Ingelheim Group
5.4. Cambrex Corporation
5.5. Dr. Reddy’s Laboratories Ltd.
5.6. Hospira, Inc.
5.7. Lonza Group
5.8. Mylan, Inc.
5.9. Novartis International AG
5.10. Pfizer, Inc.
5.11. Teva Pharmaceutical Industries Ltd.
5.12. WuXi Apptec

Request market specific full ToC and sample pages for this report

Full Name*

Email*

Phone Number* [Please add country code]

Subject*

Message*

Translate »